Atypical haemolytic uraemic syndrome (aHUS) is a form of thrombotic microangiopathy precipitated by unopposed complement activation. the treatment of which has been revolutionised by the availability of the monoclonal anti-complement (C5) antibody. eculizumab. Historically. https://parisnaturalfoodes.shop/product-category/herbatint-6d/